Date of this Version
8-23-2019
Document Type
Article
Abstract
Aim
To summarize the evidence on diabetes risk scores for Latin American populations.
Methods
A systematic review was conducted (CRD42019122306) looking for diagnostic and prognostic models for type 2 diabetes mellitus among randomly selected adults in Latin America. Five databases (LILACS, Scopus, MEDLINE, Embase and Global Health) were searched. type 2 diabetes mellitus was defined using at least one blood biomarker and the reports needed to include information on the development and/or validation of a multivariable regression model. Risk of bias was assessed using the PROBAST guidelines.
Results
Of the 1500 reports identified, 11 were studied in detail and five were included in the qualitative analysis. Two reports were from Mexico, two from Peru and one from Brazil. The number of diabetes cases varied from 48 to 207 in the derivations models, and between 29 and 582 in the validation models. The most common predictors were age, waist circumference and family history of diabetes, and only one study used oral glucose tolerance test as the outcome. The discrimination performance across studies was ~ 70% (range: 66–72%) as per the area under the receiving‐operator curve, the highest metric was always the negative predictive value. Sensitivity was always higher than specificity.
Conclusion
There is no evidence to support the use of one risk score throughout Latin America. The development, validation and implementation of risk scores should be a research and public health priority in Latin America to improve type 2 diabetes mellitus screening and prevention.
Identifier
FIDC008115
Recommended Citation
Carrillo, R.M.; Aparcana-Granda, D. J.; Mejia, J. R.; Barengo, Noel C.; and Bernabe-Ortiz, A., "Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population‐based studies" (2019). HWCOM Faculty Publications. 155.
https://digitalcommons.fiu.edu/com_facpub/155
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Rights Statement
In Copyright. URI: http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
Comments
Originally published in Diabetic Medicine.